vimarsana.com
Home
Live Updates
EU Nephrologists Foresee Travere/CSL Vifor's FILSPARITM : vimarsana.com
EU Nephrologists Foresee Travere/CSL Vifor's FILSPARITM : vimarsana.com
EU Nephrologists Foresee Travere/CSL Vifor's FILSPARITM
Data from Spherix Global Insights' second annual EU IgAN patient chart audit indicates that even with the EMA approval of FILSPARITM (sparsentan),...
Related Keywords
France ,
China ,
United Kingdom ,
Spain ,
Germany ,
Italy ,
Japan ,
Ionis Roche ,
Novartis ,
European Medicines Agency ,
Spherix Network ,
Linkedin ,
Spherix Global Insight ,
Patient Chart ,
Iga Nephropathy ,
Rare Glomerular Diseases ,
Vera Therapeutics ,
Chart Dynamix ,
Global Insights ,
Spherix Global Insights ,
Harmaceuticals ,
Ephrology ,
Ephrologist ,
Ga Nephropathy ,
Gan ,
Lomerular Diseases ,
Ravere ,
Sl Vifor ,
Ilspari ,
Glt2 Inhibitors ,